Tag Tal Galit

17 Dec

Hadassah and Neurogenesis announce results from Phase 2 MS Study

A Phase 2 study at Hadassah Hospital Ein Kerem has revealed significant clinical improvements in patients with progressive multiple sclerosis (MS) after being treated with NG-01 stem cells developed by NeuroGenesis, a clinical-stage biopharmaceutical company advancing innovative cell therapies to combat neurodegenerative diseases. The 14-month randomized, double blind, placebo-controlled study, comprised of 48 patients, was led by Prof. […]

READ MORE

10 Dec

Hadassah Hospital’s Stem Cell research results shows promise for a treatment for Progressive MS

Breaking news: The results of the latest M.S. research project study at Hadassah Hospitals in Jerusalem are just published in “Brain” Journal of Neurology by Oxford Academic. Hadassah UK is proud to have supported Multiple Sclerosis research at Hadassah by a team led by Prof. Dimitrios Karussis. Prof. Karussis’ team study is a culmination of […]

READ MORE